ArticleActa pharmacologica Sinica2025

Modeling exposure-driven adverse events of EGFR TKIs in the treatment of patients with non-small cell lung cancer.

Ling Yong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.